According to Cheng et al (281), in stable ischemic heart disease, BNP and NT-proBNP display strong and near-identical test performance in ruling out severely reduced LVEF and in prediction of all-cause mortality or heart failure despite significant effects of age, gender, and renal function on levels of both markers. This evidence concerns the gene NPPB and coronary artery disorder.